Liam J. Kelly serves as the Chairman, President, and Chief Executive Officer at Teleflex Incorporated, a global provider of medical technologies. With a strong background in healthcare and business leadership, Kelly has been instrumental in driving the company's growth and innovation. He joined Teleflex in January 2018 as President and CEO and was appointed Chairman of the Board in April 2020. Under his leadership, Teleflex has focused on expanding its portfolio of life-saving medical devices and strengthening its position in the global market. Prior to joining Teleflex, Kelly held several key executive positions in the healthcare industry. He spent over a decade at Covidien, where he served as President of the Surgical and Energy businesses. During his tenure, he was responsible for driving significant growth and innovation in these product lines. Before Covidien, Kelly worked at Johnson & Johnson, where he held various leadership roles in sales, marketing, and general management. His extensive experience in the medical device sector has been a valuable asset to Teleflex, enabling the company to navigate complex market dynamics and deliver high-quality products to healthcare providers worldwide. As Chairman, President, and CEO, Liam J. Kelly is responsible for setting the strategic direction of Teleflex and overseeing its day-to-day operations. He has been a strong advocate for the company's mission to improve the health and well-being of people around the world. Under his leadership, Teleflex has made significant investments in research and development, resulting in the launch of several innovative products that have improved patient outcomes. Kelly's vision and leadership have been crucial in positioning Teleflex as a leader in the medical technology industry, and he continues to drive the company towards a future of sustainable growth and success.